<DOC>
	<DOCNO>NCT01248117</DOCNO>
	<brief_summary>Monthly , continuous anti-vegf therapy patient present active polypoidal choroidal vasculopathy . Two arm , treatment naive previously treat FDA approve anti-VEGF therapy , randomize dose open label 2.0mg ranibizumab .</brief_summary>
	<brief_title>Safety Study High-Dose Ranibizumab Polypoidal Choroidal Vasculopathy</brief_title>
	<detailed_description>Patients follow spectral oct , 4m BCVA , ICG , FA monthly eye examination one year .</detailed_description>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>Ability provide write informed consent comply study assessment full duration study Age &gt; = 25 year Polypoidal choroidal vasculopathy note fluorescein ICG angiography : active leakage , active bleeding recent decrease vision BVCA use ETDRS 20/32 20/400 Any history prior vitrectomy Any prior treatment verteporfin PDT study eye Previous cataract surgery within precede 2 month D0 Active intraocular inflammation study eye Active infectious conjunctivitis , keratitis , scleritis , endophthalmitis either eye A condition , opinion investigator , would preclude participation study ( e.g . unstable medical status include blood pressure , cardiovascular disease ) Participation another investigational trial within 30 day randomization involve treatment drug receive regulatory approval time study entry . Prior antiVEGF ( Macugen , Avastin , Lucentis ) study eye within 30 day prior enrollment study Known allergy component study drug Uncontrolled hypertension : &gt; 180/110 major surgery within 28 day prior randomization Myocardial infarction , cardia event require hospitalization within 6 month prior randomization Systemic antiVEGF proVEGF within 3 month randomization Pregnancy lactation History recurrent significant infection bacterial infection</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>PCV</keyword>
	<keyword>polypoidal</keyword>
	<keyword>choroidal</keyword>
	<keyword>vasculopathy</keyword>
</DOC>